SlideShare a Scribd company logo
PATHOPHYSIOLOGY,
HEMODYNAMICS
AND NATURAL
HISTORY OF VSD
EMBYOLOGY OF IVS
 Parts of IVS :
- Membranous septum: Ventriculoatrial + Interventricular components
- Muscular septum: Inlet septum(lightly trabeculated)
Trabecular septum(heavily trabeculated)
Infundibular septum(non-trabeculated)
 VSD - m.c. congenital malformation of the heart(excluding BAV) – 20-30% of children in India with CHD
- Saxena, et al .: Indian Guidelines for Management of CHDs - Annals of Pediatric Cardiology / Volume 12 / Issue 3 / Sept-Dec 2019
 Classification of VSD :
- initiated by Soto et al in 1980
- further modified by Anderson, VanPraagh, Casteneda and others
Morphologic Classification of Ventricular Septal
Defect
PATHOPHYSIOLOGY
Left  Right shunt
Large pulmonary flow(↑Qp)
LA/LV Enlarged (Stage I)
↑Qp with PAH
Biventricular Enlargement (Stage II)
Severe PAH(Muscle hypertrophy + Intimal proliferation and fibrosis)
Shunt reversal (R L) LA/LV Normal size (Stage III)
Factors that influence the hemodynamics of VSD
 The size of the VSD
 Pressure gradient across RV/LV
 Pulmonary vascular resistance
 VSD may not be apparent at birth because of the nearly equal pressures in the right and left
ventricles and a lack of shunting.
 With increasing shunt corresponding to the increasing pressure difference between the ventricles,
these defects become clinically apparent.
RVSP PA PVR SHUNT HEMODYNAMICS
RESTRICTIVE VSD
< 1/3rd of Ao Orifice
NORMAL NORMAL NORMAL SMALL(1.5 : 1)
SYSTOLIC
NORMAL (LV PRESSURES are not
transmitted to RV)
MOD.RESTRICTIVE
VSD
1/3rd - 3/4th of Ao
Orifice
> NORMAL SUB-
SYSTEMIC
LOW
VARIABLE
MODERATE(1.5-2.2 : 1)
SYSTOLIC,DIASTOLIC
(LV VOO)
LV -↑VOO
RV -↑POO
NON-RESTRICTIVE
VSD - HIGH &
VARIABLE PVR
≥ 3/4th of Ao Orifice
RVSP ≈ LVSP
COMMON
CHAMBER
PA ≈ Ao HIGH
VARIABLE
PERSISTENTLY LARGE
(>2.2 : 1)
PVR dependent FLOW
LV -↑↑↑VOO
-SYSTOLIC DYSFUNCTION
RV -↑↑↑POO(SYSTEMIC AFTERLOAD)
PVR-HIGH
NON-RESTRICTIVE
VSD – HIGH &
PVR
RVSP > LVSP PA > Ao HIGH
FIXED
RIGHT LEFT EISENMENGERISATION of pulmonary
vasculature
 Restrictive VSD - Small (≤1.4 : 1) shunt due to significant pressure gradient between LV
and RV(pulmonary-to-aortic systolic pressure ratio < 0.3)
 Moderately restrictive VSD - moderate shunt (Qp/Qs of 1.4 to 2.2 : 1) with a
pulmonary-to-aortic systolic pressure ratio <0.66
 Large or nonrestrictive VSD - large shunt (Qp/Qs > 2.2) and a pulmonary-to-aortic
systolic pressure ratio >0.66.
 Eisenmenger VSD has a systolic pressure ratio of 1 and Qp/Qs less than 1 : 1 or a net
right-to-left shunt.
CLINICALLY
 RESTRICTIVE VSD :
- Asymtomatic and lives long
- Systolic murmur
- CXR and ECG may be completely normal
- IE is a usual risk d/t effect of shunt jet on STL
- More chances of Spontaneous closure
 MODERATELY RESTRICTIVE VSD :
- Symptomatic d/t ↑Qp – Easy fatiguability
Cough while feeding
Excessive Sweating
Restless on recumbent position and poor sleep
Gets better with Isotonic exercise d/t fall in SVR
- Delayed onset of murmur because delayed fall in PVR and can lead to CCF
- Thrill and Hyperactive precardium
- CXR shows Cardiomegaly, increased pulmonary vascularity with prominent PA segment is suggestive of
significant left-to-right flow.
- ECG shows LV VOO, LVH, LAE or BiVH
- Risk of IE and CCF because of LV VOO
- Rarely reaches adulthood, if not intervened
 LVH – Voltage criteria ( S in V1 + R in V5/V6 > 35mm or R in V5/V6 > 25mm)
 Left Axis Deviation
 LV strain pattern – ST depressions in V5/V6 with corresponding ST elevations in V1/V2/V3,
U waves in V1-V4
 Radiological features : Based on grades of PAH
Grade Mean PA
pressure
Systolic PA
pressure
Pacifico classification
(Ratio of PA systolic &
systemic systolic)
Radiological features
Mild 25-40 25-49 1/3-1/2 MPA dilatation
Moderate 41-55 50-69 1/2- 2/3 MPA dilatation
Rt Descending PA dilatation (>14-16 mm)
Mild peripheral pruning
Severe >55 >70 >2/3 Severe MPA dilatation ( +calcification)
Severe Hilar prominence
Severe pruning
RV enlargement ( Loss of retrosternal space)
MPA dilatation
Rt Descending PA dilatation
Mild peripheral pruning
Severe MPA dilatation ( +calcification)
Severe Hilar prominence
Severe pruning
RV enlargement ( Loss of retrosternal space)
 Non-Restrictive VSD :
- Present in infancy with CCF
- Symptomatology - Poor growth and development
Laboured breathing
Frequent URTI
Difficulty feeding and diaphoresis
Dyspnoea and irritability on lying down-improves with sitting
Suck-Rest-Suck cycles
Wakes up and
starts feeding
Feeds short of
satisfaction d/t
dyspnoea
Exhausted
Falls asleep
Hungry infant
EISENMENGER’S SYNDROME
 Regulation of shunt through a Non-restrictive VSD with amelioration of symptoms is almost always a
result of rise in PVR    Eisenmenger’s syndrome
 Victor Eisenmenger first identified and published in 1897”Congenital Defects of the Ventricular
Septum”
 Maude Abbott, a Canadian physician, named the condition as Eisenmenger’s complex(1936)
 Paul Wood, a British Cardiologist, defined this pulmonary HTN with reversed shunt as Eisenmenger’s
syndrome(1958)
It is a multisystem disorder involving :
 Red cell mass, Hemostasis
 Systemic vascular bed
 CNS
 Bilirubin kinetics
 Coronary circulation and Myocardium
 Uric acid Clearence
 Kidney
 Respiratory system
 Digits and long bones
 Gynecologic endocrinology
PATHOPHYSIOLOGY
Right  Left shunt
Cyanosis + ↓Tissue Oxygenation
Arterial Hypoxemia
Adaptive Erythrocytosis
↑ Hematocrit
↑ RBC turnover & Hemolysis
Indirect Bilirubinemia+Gall Stones
EXTRAMURAL CORONARY ECTASIA
Iron Deficiency(≤ 4 yrs)
CEREBRAL VENOUS THROMBOSIS
Paradoxical Emboli
STROKE
Thrombocytopenia(≥ 50yrs)
+
Abnormal vWF
Muco-cutaneous bleeding
Easy Bruising, Epistaxis,
Gingival bleeding, Menorrhagia,
PULM.HEMORRHAGE(MOST SERIOUS)
SUDDEN DEATH
↑ Shear stress in blood vessels
↑ NO,PGs
SYSTEMIC VASCULAR DILATION
SYNCOPE
Dilation of Hilar Arterioles +
Glomerular Capillaries
↑ PGDF,TGF β
PROTENURIA + GLOMERULOPATHY
Remodelling of
Coronary Microvasculature
↓ CORONARY VASCULAR
RESERVE
CLUBBING+HYPERTROPHIC
OSTEOARTHROPATHY
Hyperuricemia
Renal Calculi,Gouty Arthritis
GERBODE DEFECT ~0.08% of CHD
 LV–RA communications - congenital >> acquired-Post-MI, trauma, surgical, IE
 First mentioned in 1838 by Thurnam J. On aneurisms of the heart with cases(Autopsy report)
 First diagnosed by Kirby et al in a living patient directly on O.T table,18 Jan.1956 and closed it
successfully through right thoracotomy by inflow occlusion + Hypothermia
 In 1958, Gerbode et al successfully performed surgery on five patients with this anomaly and named
it Gerbode defect
 Caused by an anatomic deficiency of the membranous septum
The Gerbode Defect: Left Ventricular to Right Atrial Communication—Anatomic, Hemodynamic, and Echocardiographic Features - SILBIGER, ET AL - ECHOCARDIOGRAPHY: A Jrnl.
of CV Ultrasound & Allied Tech - 2009
Modified Riemenschneider and Moss Classification
1/3rd cases associated with other anomalies – most common being ASD(PFO/Secumdum ASD)
Aneurysmal transformation – Wu et al
Morphogenetic process for Infra-valvular shunts
LV  RA
Large Systolic ∆ + Small Diastolic ∆
SHUNT depends on Size & PVR
Large Shunt
RA/RV Enlarged
↑ RV preload  LV
LA/LV Enlarged
Severe PAH may develop but uncommon
Biventricular overload
Acute/Chronic Heart Failure
RL shunt caused by
(1) Diastolic flow reversal across defect (RALV)
(2) continuous RALA shunt across PFO/OS-ASD
 Asymptomatic to severe heart failure
 Characteristic murmur : loud, harsh pansystolic, Grade III–VI, getting softer with inspiration, radiationing
posteriorly and often associated with a thrill along the left sternal border –
SEA GULL MURMUR
 Raised JVP, liver pulsation, and peripheral edema indicating RHF
NATURAL HISTORY
 Refers to the progression of a disease process in an individual over time, in the absence of treatment
 Spontaneous closure
 Premature death
 Pulmonary vascular disease
 Development of aortic incompetence
 Bacterial endocarditis
 Development of infundibular PS
Spon Closure Rate
 Rate of spontaneous closure depends on SIZE and LOCATION of VSD
 Muscular VSDs are more likely to close spontaneously, especially if they are not large
 Small VSDs have a >50% chance of spontaneous closure by 5 years
>80% chance by adolescence
Saxena, et al .: Indian Guidelines for Management of CHDs - Annals of Pediatric Cardiology / Volume 12 / Issue 3 / Sept-Dec 2019
 Perimembranous VSDs (accounted for most of the moderate to large VSDs)
39% required surgical closure
29% closed spontaneously by 6 years of age
 Muscular VSDs – 3% required surgical closure
69% closed spontaneously by 6 years of age
The natural history of ventricular septal defects - S W Turner, S Hunter, J P Wyllie
 Most of the VSDs(~75%) close spontaneously within the first two years of life
 Afterwards, the chance of spontaneous closure diminishes remarkably but extend till adolescence.
 Muscular and membranous VSDs with diameters < 6 mm have the best chance of spontaneous closure
Spontaneous closure of ventricular septal defects in the first year of life - Lin MH et al - J Formos Med Assoc. 2001
Age-wise Probability of Spontaneous closure of Small VSD :
 34% by 1 year
 67% by 5 years
 75% by 10.5 years
Mech of closure
 Adherence of tricuspid leaflet , or chordal tissue to the edges of VSD.
 Growth & hypertrophy of septum around the defect
 Negative pressure effect exerted by a high velocity stream flowing through the
defect
 Ventricular septal aneurysm
 Prolapse of aortic cusp
 Intrusion of a sinus of Valsalva aneurysm
VSD unlikely to close
 Sub-pulmonary
 Juxta-arterial
 Inlet
 Mal-aligned
 Gerbode defect
 Very large
Saxena, et al .: Indian Guidelines for Management of CHDs - Annals of Pediatric Cardiology / Volume 12 / Issue 3 / Sept-Dec 2019
Premature death
 About 10% of children with large VSDs die in 1st year, primarily due to congestive heart failure Saxena,
Pul vascular disease
In the historic series of Dr. Paul Wood, 52% of patients with large VSD developed irreversible pulmonary
vascular disease with the onset in infancy in four-fifths of them
 Common with Subpulmonary VSD
 Chances of development of PVD with age (PVR > 8 U.m2)
YR Probability
10 yr 10 %
20 yr 50 %
30 yr 80 %
40 yr 100 %
Updated clinical classification for PAH associated with
CHD, Nice, France, 2013.
Development of AR – seen in 6%
Mechanism :
 Lack of support to aortic annulus : Diastolic prolapse of unsupported cusp.
 Venturi effect : Cusp is sucked during systole
More with Subaortic/ Juxtaarterial VSD and Smaller VSD
Bacterial endocarditis : 2-3 decade, on right side
 Among congenital heart disease, VSD is the most frequent anomaly in right- sided IE
 One of the important indications for VSD closure
 The incidence of IE among ventricular septal defects (VSD) was 0.2%- 2%
 Baumgartner et al.Guidelines for the management of grown- up congenital heart disease (new version 2010). Eur Heart J. 2010.
Development of infundibular PS : 13 % pts
Gasul Syndrome :
 VSD with acquired PS, Gasul found that about 5- 10 % VSD patients develop PS in follow up(JAMA
1957, circulation 1963)
 Progressive right ventricular outflow tract obstruction (Gasul phenomenon) may develop in 13% and
aortic regurgitation (AR) in 6% of patients

More Related Content

What's hot

tetrology of fallot (TOF) with pulmonary atresia
tetrology of fallot (TOF) with pulmonary atresiatetrology of fallot (TOF) with pulmonary atresia
tetrology of fallot (TOF) with pulmonary atresia
Malleswara rao Dangeti
 
Echo assessment of RV function
Echo assessment of RV functionEcho assessment of RV function
Echo assessment of RV function
Dr. Md. Ahasanul Kabir Shahin
 
Double outlet right ventricle
Double outlet right ventricleDouble outlet right ventricle
Double outlet right ventricle
Himanshu Rana
 
Echocardiography in mitral stenosis
Echocardiography in mitral stenosisEchocardiography in mitral stenosis
Echocardiography in mitral stenosis
Malleswara rao Dangeti
 
Ventricular Septal Defects - A Review
Ventricular Septal Defects - A ReviewVentricular Septal Defects - A Review
Ventricular Septal Defects - A Review
Vivek Rana
 
Pulmonary atresia with intact interventricular septum
Pulmonary atresia with intact interventricular septum Pulmonary atresia with intact interventricular septum
Pulmonary atresia with intact interventricular septum
Ramachandra Barik
 
Atrial septal defect
Atrial septal defectAtrial septal defect
Atrial septal defect
Shabnam Mohammadzadeh
 
Aortic stenosis - Echocardiography
Aortic stenosis - EchocardiographyAortic stenosis - Echocardiography
Aortic stenosis - Echocardiography
Ankur Gupta
 
Assessment of shunt by cardiac catheterization
Assessment of shunt by cardiac catheterizationAssessment of shunt by cardiac catheterization
Assessment of shunt by cardiac catheterization
Ramachandra Barik
 
Intracardiac shunts
Intracardiac shuntsIntracardiac shunts
Intracardiac shuntsFuad Farooq
 
interesting ECG,CXR,ECHO, EP
interesting ECG,CXR,ECHO, EPinteresting ECG,CXR,ECHO, EP
interesting ECG,CXR,ECHO, EP
SR,CARDIOLOGY,JIPMER,PUDUCHERRY
 
Admixture lesions in congenital cyanotic heart disease
Admixture lesions in congenital cyanotic heart diseaseAdmixture lesions in congenital cyanotic heart disease
Admixture lesions in congenital cyanotic heart disease
Ramachandra Barik
 
MVP Mitral Valve Prolapse - Echocardiographic Evaluation
 MVP Mitral Valve  Prolapse - Echocardiographic Evaluation MVP Mitral Valve  Prolapse - Echocardiographic Evaluation
MVP Mitral Valve Prolapse - Echocardiographic Evaluation
Praveen Nagula
 
Shunt quantification and reversibility
Shunt quantification and reversibilityShunt quantification and reversibility
Shunt quantification and reversibility
GOPAL GHOSH
 
Double outlet right ventricle
Double outlet right ventricleDouble outlet right ventricle
Double outlet right ventricle
Ramachandra Barik
 
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
Praveen Nagula
 
VSD : Dr. Akif Baig
VSD : Dr. Akif BaigVSD : Dr. Akif Baig
VSD : Dr. Akif Baig
akifab93
 
Bicuspid aortic valve
Bicuspid aortic valveBicuspid aortic valve
Bicuspid aortic valve
Jyotindra Singh
 

What's hot (20)

tetrology of fallot (TOF) with pulmonary atresia
tetrology of fallot (TOF) with pulmonary atresiatetrology of fallot (TOF) with pulmonary atresia
tetrology of fallot (TOF) with pulmonary atresia
 
Echo assessment of RV function
Echo assessment of RV functionEcho assessment of RV function
Echo assessment of RV function
 
Vsd
VsdVsd
Vsd
 
Double outlet right ventricle
Double outlet right ventricleDouble outlet right ventricle
Double outlet right ventricle
 
Echocardiography in mitral stenosis
Echocardiography in mitral stenosisEchocardiography in mitral stenosis
Echocardiography in mitral stenosis
 
Ventricular Septal Defects - A Review
Ventricular Septal Defects - A ReviewVentricular Septal Defects - A Review
Ventricular Septal Defects - A Review
 
Pulmonary atresia with intact interventricular septum
Pulmonary atresia with intact interventricular septum Pulmonary atresia with intact interventricular septum
Pulmonary atresia with intact interventricular septum
 
Atrial septal defect
Atrial septal defectAtrial septal defect
Atrial septal defect
 
Aortic stenosis - Echocardiography
Aortic stenosis - EchocardiographyAortic stenosis - Echocardiography
Aortic stenosis - Echocardiography
 
Assessment of shunt by cardiac catheterization
Assessment of shunt by cardiac catheterizationAssessment of shunt by cardiac catheterization
Assessment of shunt by cardiac catheterization
 
Intracardiac shunts
Intracardiac shuntsIntracardiac shunts
Intracardiac shunts
 
interesting ECG,CXR,ECHO, EP
interesting ECG,CXR,ECHO, EPinteresting ECG,CXR,ECHO, EP
interesting ECG,CXR,ECHO, EP
 
Admixture lesions in congenital cyanotic heart disease
Admixture lesions in congenital cyanotic heart diseaseAdmixture lesions in congenital cyanotic heart disease
Admixture lesions in congenital cyanotic heart disease
 
MVP Mitral Valve Prolapse - Echocardiographic Evaluation
 MVP Mitral Valve  Prolapse - Echocardiographic Evaluation MVP Mitral Valve  Prolapse - Echocardiographic Evaluation
MVP Mitral Valve Prolapse - Echocardiographic Evaluation
 
Shunt quantification and reversibility
Shunt quantification and reversibilityShunt quantification and reversibility
Shunt quantification and reversibility
 
EISENMENGER SYNDROME- PAUL WOOD
EISENMENGER SYNDROME- PAUL WOODEISENMENGER SYNDROME- PAUL WOOD
EISENMENGER SYNDROME- PAUL WOOD
 
Double outlet right ventricle
Double outlet right ventricleDouble outlet right ventricle
Double outlet right ventricle
 
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATIONECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
ECHOCARDIOGRAPHIC EVALUATION OF MITRAL VALVE DISEASE -MITRAL REGURGITATION
 
VSD : Dr. Akif Baig
VSD : Dr. Akif BaigVSD : Dr. Akif Baig
VSD : Dr. Akif Baig
 
Bicuspid aortic valve
Bicuspid aortic valveBicuspid aortic valve
Bicuspid aortic valve
 

Similar to PATHOPHYSIOLOGY ,NATURAL HISTORY OF VSD

Valvular heart disease.ppt
Valvular heart disease.pptValvular heart disease.ppt
Valvular heart disease.ppt
RAHULSUTHAR46
 
Mitral stenosis
Mitral stenosisMitral stenosis
Mitral stenosis
Dharmraj Singh
 
Congenital Heart Disease acyanotic.pptx
Congenital Heart Disease  acyanotic.pptxCongenital Heart Disease  acyanotic.pptx
Congenital Heart Disease acyanotic.pptx
jebaraj66
 
5 Congenital Heart Disease(Chd)
5 Congenital Heart Disease(Chd)5 Congenital Heart Disease(Chd)
5 Congenital Heart Disease(Chd)ghalan
 
Ebstein’s anomaly & Truncus Arteriosus
Ebstein’s anomaly & Truncus ArteriosusEbstein’s anomaly & Truncus Arteriosus
Ebstein’s anomaly & Truncus ArteriosusTarun Bhatnagar
 
An approach to a patient with ventricular septal defect
An approach to a patient with ventricular septal defect An approach to a patient with ventricular septal defect
An approach to a patient with ventricular septal defect
PROFESSOR DR. MD. TOUFIQUR RAHMAN
 
Ebstein’s anomaly & Truncus Arteriosus
Ebstein’s anomaly & Truncus ArteriosusEbstein’s anomaly & Truncus Arteriosus
Ebstein’s anomaly & Truncus Arteriosus
Tarun Bhatnagar
 
Asd and vsd
Asd and vsdAsd and vsd
Asd and vsd
Mohit Aggarwal
 
Dorv thab
Dorv thab Dorv thab
Dorv thab
Thabit Ahmed
 
Anaesthetic management of mitral valvular heart disease
Anaesthetic management of mitral valvular heart diseaseAnaesthetic management of mitral valvular heart disease
Anaesthetic management of mitral valvular heart diseaseDhritiman Chakrabarti
 
V s d may 2021
V s d  may 2021V s d  may 2021
V s d may 2021
rajasthan govt
 
Ventricular septal defects
Ventricular septal defectsVentricular septal defects
Ventricular septal defects
Dheeraj Sharma
 
Ventricular Septal Defect
Ventricular Septal DefectVentricular Septal Defect
Ventricular Septal Defect
Dhanesh Bhardwaj
 
Right ventricular infarction & posterior extension by dr salim
Right ventricular infarction & posterior extension by dr salimRight ventricular infarction & posterior extension by dr salim
Right ventricular infarction & posterior extension by dr salim
Salimshaheer
 
Ventricular septal defect, congenital heart disease
Ventricular septal defect,  congenital heart diseaseVentricular septal defect,  congenital heart disease
Ventricular septal defect, congenital heart disease
Shabnam Mohammadzadeh
 
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Ankur Khandelwal
 
Eisenmenger syndrome
Eisenmenger syndromeEisenmenger syndrome
Eisenmenger syndrome
Kapil Vasanth
 
Right ventricular infarction
Right ventricular infarctionRight ventricular infarction
Right ventricular infarction
Vijay Yadav
 
Cyanotic congenital heart diseases
Cyanotic congenital heart diseasesCyanotic congenital heart diseases
Cyanotic congenital heart diseases
AkeFid
 

Similar to PATHOPHYSIOLOGY ,NATURAL HISTORY OF VSD (20)

Valvular heart disease.ppt
Valvular heart disease.pptValvular heart disease.ppt
Valvular heart disease.ppt
 
Mitral stenosis
Mitral stenosisMitral stenosis
Mitral stenosis
 
Congenital Heart Disease acyanotic.pptx
Congenital Heart Disease  acyanotic.pptxCongenital Heart Disease  acyanotic.pptx
Congenital Heart Disease acyanotic.pptx
 
5 Congenital Heart Disease(Chd)
5 Congenital Heart Disease(Chd)5 Congenital Heart Disease(Chd)
5 Congenital Heart Disease(Chd)
 
Ebstein’s anomaly & Truncus Arteriosus
Ebstein’s anomaly & Truncus ArteriosusEbstein’s anomaly & Truncus Arteriosus
Ebstein’s anomaly & Truncus Arteriosus
 
An approach to a patient with ventricular septal defect
An approach to a patient with ventricular septal defect An approach to a patient with ventricular septal defect
An approach to a patient with ventricular septal defect
 
Ebstein’s anomaly & Truncus Arteriosus
Ebstein’s anomaly & Truncus ArteriosusEbstein’s anomaly & Truncus Arteriosus
Ebstein’s anomaly & Truncus Arteriosus
 
Asd and vsd
Asd and vsdAsd and vsd
Asd and vsd
 
Dorv thab
Dorv thab Dorv thab
Dorv thab
 
Hypertension & heart
Hypertension & heartHypertension & heart
Hypertension & heart
 
Anaesthetic management of mitral valvular heart disease
Anaesthetic management of mitral valvular heart diseaseAnaesthetic management of mitral valvular heart disease
Anaesthetic management of mitral valvular heart disease
 
V s d may 2021
V s d  may 2021V s d  may 2021
V s d may 2021
 
Ventricular septal defects
Ventricular septal defectsVentricular septal defects
Ventricular septal defects
 
Ventricular Septal Defect
Ventricular Septal DefectVentricular Septal Defect
Ventricular Septal Defect
 
Right ventricular infarction & posterior extension by dr salim
Right ventricular infarction & posterior extension by dr salimRight ventricular infarction & posterior extension by dr salim
Right ventricular infarction & posterior extension by dr salim
 
Ventricular septal defect, congenital heart disease
Ventricular septal defect,  congenital heart diseaseVentricular septal defect,  congenital heart disease
Ventricular septal defect, congenital heart disease
 
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
Anaesthetic management of a patient with mitral stenosis put for non-cardiac ...
 
Eisenmenger syndrome
Eisenmenger syndromeEisenmenger syndrome
Eisenmenger syndrome
 
Right ventricular infarction
Right ventricular infarctionRight ventricular infarction
Right ventricular infarction
 
Cyanotic congenital heart diseases
Cyanotic congenital heart diseasesCyanotic congenital heart diseases
Cyanotic congenital heart diseases
 

More from India CTVS

Weaning from MECHANICAL VENTILATION
Weaning  from MECHANICAL VENTILATIONWeaning  from MECHANICAL VENTILATION
Weaning from MECHANICAL VENTILATION
India CTVS
 
Tracheostomy
TracheostomyTracheostomy
Tracheostomy
India CTVS
 
Protocol for ventilator settings
Protocol for ventilator settingsProtocol for ventilator settings
Protocol for ventilator settings
India CTVS
 
Infective endocardiitis
Infective endocardiitis  Infective endocardiitis
Infective endocardiitis
India CTVS
 
Management of cc tga
Management of cc tgaManagement of cc tga
Management of cc tga
India CTVS
 
Iabp presentation
Iabp presentationIabp presentation
Iabp presentation
India CTVS
 
Coagulation monitoring and teg
Coagulation monitoring and tegCoagulation monitoring and teg
Coagulation monitoring and teg
India CTVS
 
Coronary artery anomalies in chd
Coronary artery anomalies in chd Coronary artery anomalies in chd
Coronary artery anomalies in chd
India CTVS
 
Adult ecmo
Adult ecmo Adult ecmo
Adult ecmo
India CTVS
 
Evolution of management stratergy for TGA
Evolution of management stratergy for TGAEvolution of management stratergy for TGA
Evolution of management stratergy for TGA
India CTVS
 
Heart transplant guidelines
Heart transplant guidelines Heart transplant guidelines
Heart transplant guidelines
India CTVS
 
HYPOPLASTIC LEFT HEART SYNDROME
HYPOPLASTIC LEFT HEART SYNDROMEHYPOPLASTIC LEFT HEART SYNDROME
HYPOPLASTIC LEFT HEART SYNDROME
India CTVS
 
Pumps, oxygenators and priming solution
Pumps, oxygenators and priming solutionPumps, oxygenators and priming solution
Pumps, oxygenators and priming solution
India CTVS
 
Blood presentation
Blood presentation Blood presentation
Blood presentation
India CTVS
 
Tga management
Tga managementTga management
Tga management
India CTVS
 
Pediatric ecmo
Pediatric ecmo Pediatric ecmo
Pediatric ecmo
India CTVS
 
Management of tapvc
Management of tapvcManagement of tapvc
Management of tapvc
India CTVS
 
Constrictive pericarditis pathophysiology
Constrictive pericarditis pathophysiologyConstrictive pericarditis pathophysiology
Constrictive pericarditis pathophysiology
India CTVS
 
Mechanical heart valve substitutes
Mechanical heart valve substitutesMechanical heart valve substitutes
Mechanical heart valve substitutes
India CTVS
 
Bioprostheic heart valve prosthesis
Bioprostheic heart valve prosthesisBioprostheic heart valve prosthesis
Bioprostheic heart valve prosthesis
India CTVS
 

More from India CTVS (20)

Weaning from MECHANICAL VENTILATION
Weaning  from MECHANICAL VENTILATIONWeaning  from MECHANICAL VENTILATION
Weaning from MECHANICAL VENTILATION
 
Tracheostomy
TracheostomyTracheostomy
Tracheostomy
 
Protocol for ventilator settings
Protocol for ventilator settingsProtocol for ventilator settings
Protocol for ventilator settings
 
Infective endocardiitis
Infective endocardiitis  Infective endocardiitis
Infective endocardiitis
 
Management of cc tga
Management of cc tgaManagement of cc tga
Management of cc tga
 
Iabp presentation
Iabp presentationIabp presentation
Iabp presentation
 
Coagulation monitoring and teg
Coagulation monitoring and tegCoagulation monitoring and teg
Coagulation monitoring and teg
 
Coronary artery anomalies in chd
Coronary artery anomalies in chd Coronary artery anomalies in chd
Coronary artery anomalies in chd
 
Adult ecmo
Adult ecmo Adult ecmo
Adult ecmo
 
Evolution of management stratergy for TGA
Evolution of management stratergy for TGAEvolution of management stratergy for TGA
Evolution of management stratergy for TGA
 
Heart transplant guidelines
Heart transplant guidelines Heart transplant guidelines
Heart transplant guidelines
 
HYPOPLASTIC LEFT HEART SYNDROME
HYPOPLASTIC LEFT HEART SYNDROMEHYPOPLASTIC LEFT HEART SYNDROME
HYPOPLASTIC LEFT HEART SYNDROME
 
Pumps, oxygenators and priming solution
Pumps, oxygenators and priming solutionPumps, oxygenators and priming solution
Pumps, oxygenators and priming solution
 
Blood presentation
Blood presentation Blood presentation
Blood presentation
 
Tga management
Tga managementTga management
Tga management
 
Pediatric ecmo
Pediatric ecmo Pediatric ecmo
Pediatric ecmo
 
Management of tapvc
Management of tapvcManagement of tapvc
Management of tapvc
 
Constrictive pericarditis pathophysiology
Constrictive pericarditis pathophysiologyConstrictive pericarditis pathophysiology
Constrictive pericarditis pathophysiology
 
Mechanical heart valve substitutes
Mechanical heart valve substitutesMechanical heart valve substitutes
Mechanical heart valve substitutes
 
Bioprostheic heart valve prosthesis
Bioprostheic heart valve prosthesisBioprostheic heart valve prosthesis
Bioprostheic heart valve prosthesis
 

Recently uploaded

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
SwisschemDerma
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 

Recently uploaded (20)

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 

PATHOPHYSIOLOGY ,NATURAL HISTORY OF VSD

  • 2.
  • 4.
  • 5.  Parts of IVS : - Membranous septum: Ventriculoatrial + Interventricular components - Muscular septum: Inlet septum(lightly trabeculated) Trabecular septum(heavily trabeculated) Infundibular septum(non-trabeculated)
  • 6.
  • 7.
  • 8.  VSD - m.c. congenital malformation of the heart(excluding BAV) – 20-30% of children in India with CHD - Saxena, et al .: Indian Guidelines for Management of CHDs - Annals of Pediatric Cardiology / Volume 12 / Issue 3 / Sept-Dec 2019  Classification of VSD : - initiated by Soto et al in 1980 - further modified by Anderson, VanPraagh, Casteneda and others
  • 9. Morphologic Classification of Ventricular Septal Defect
  • 10. PATHOPHYSIOLOGY Left  Right shunt Large pulmonary flow(↑Qp) LA/LV Enlarged (Stage I) ↑Qp with PAH Biventricular Enlargement (Stage II) Severe PAH(Muscle hypertrophy + Intimal proliferation and fibrosis) Shunt reversal (R L) LA/LV Normal size (Stage III)
  • 11. Factors that influence the hemodynamics of VSD  The size of the VSD  Pressure gradient across RV/LV  Pulmonary vascular resistance  VSD may not be apparent at birth because of the nearly equal pressures in the right and left ventricles and a lack of shunting.  With increasing shunt corresponding to the increasing pressure difference between the ventricles, these defects become clinically apparent.
  • 12.
  • 13. RVSP PA PVR SHUNT HEMODYNAMICS RESTRICTIVE VSD < 1/3rd of Ao Orifice NORMAL NORMAL NORMAL SMALL(1.5 : 1) SYSTOLIC NORMAL (LV PRESSURES are not transmitted to RV) MOD.RESTRICTIVE VSD 1/3rd - 3/4th of Ao Orifice > NORMAL SUB- SYSTEMIC LOW VARIABLE MODERATE(1.5-2.2 : 1) SYSTOLIC,DIASTOLIC (LV VOO) LV -↑VOO RV -↑POO NON-RESTRICTIVE VSD - HIGH & VARIABLE PVR ≥ 3/4th of Ao Orifice RVSP ≈ LVSP COMMON CHAMBER PA ≈ Ao HIGH VARIABLE PERSISTENTLY LARGE (>2.2 : 1) PVR dependent FLOW LV -↑↑↑VOO -SYSTOLIC DYSFUNCTION RV -↑↑↑POO(SYSTEMIC AFTERLOAD) PVR-HIGH NON-RESTRICTIVE VSD – HIGH & PVR RVSP > LVSP PA > Ao HIGH FIXED RIGHT LEFT EISENMENGERISATION of pulmonary vasculature
  • 14.  Restrictive VSD - Small (≤1.4 : 1) shunt due to significant pressure gradient between LV and RV(pulmonary-to-aortic systolic pressure ratio < 0.3)  Moderately restrictive VSD - moderate shunt (Qp/Qs of 1.4 to 2.2 : 1) with a pulmonary-to-aortic systolic pressure ratio <0.66  Large or nonrestrictive VSD - large shunt (Qp/Qs > 2.2) and a pulmonary-to-aortic systolic pressure ratio >0.66.  Eisenmenger VSD has a systolic pressure ratio of 1 and Qp/Qs less than 1 : 1 or a net right-to-left shunt.
  • 15. CLINICALLY  RESTRICTIVE VSD : - Asymtomatic and lives long - Systolic murmur - CXR and ECG may be completely normal - IE is a usual risk d/t effect of shunt jet on STL - More chances of Spontaneous closure
  • 16.  MODERATELY RESTRICTIVE VSD : - Symptomatic d/t ↑Qp – Easy fatiguability Cough while feeding Excessive Sweating Restless on recumbent position and poor sleep Gets better with Isotonic exercise d/t fall in SVR - Delayed onset of murmur because delayed fall in PVR and can lead to CCF - Thrill and Hyperactive precardium
  • 17. - CXR shows Cardiomegaly, increased pulmonary vascularity with prominent PA segment is suggestive of significant left-to-right flow. - ECG shows LV VOO, LVH, LAE or BiVH - Risk of IE and CCF because of LV VOO - Rarely reaches adulthood, if not intervened
  • 18.  LVH – Voltage criteria ( S in V1 + R in V5/V6 > 35mm or R in V5/V6 > 25mm)  Left Axis Deviation  LV strain pattern – ST depressions in V5/V6 with corresponding ST elevations in V1/V2/V3, U waves in V1-V4
  • 19.  Radiological features : Based on grades of PAH Grade Mean PA pressure Systolic PA pressure Pacifico classification (Ratio of PA systolic & systemic systolic) Radiological features Mild 25-40 25-49 1/3-1/2 MPA dilatation Moderate 41-55 50-69 1/2- 2/3 MPA dilatation Rt Descending PA dilatation (>14-16 mm) Mild peripheral pruning Severe >55 >70 >2/3 Severe MPA dilatation ( +calcification) Severe Hilar prominence Severe pruning RV enlargement ( Loss of retrosternal space)
  • 20. MPA dilatation Rt Descending PA dilatation Mild peripheral pruning
  • 21. Severe MPA dilatation ( +calcification) Severe Hilar prominence Severe pruning RV enlargement ( Loss of retrosternal space)
  • 22.  Non-Restrictive VSD : - Present in infancy with CCF - Symptomatology - Poor growth and development Laboured breathing Frequent URTI Difficulty feeding and diaphoresis Dyspnoea and irritability on lying down-improves with sitting
  • 23. Suck-Rest-Suck cycles Wakes up and starts feeding Feeds short of satisfaction d/t dyspnoea Exhausted Falls asleep Hungry infant
  • 24. EISENMENGER’S SYNDROME  Regulation of shunt through a Non-restrictive VSD with amelioration of symptoms is almost always a result of rise in PVR    Eisenmenger’s syndrome  Victor Eisenmenger first identified and published in 1897”Congenital Defects of the Ventricular Septum”  Maude Abbott, a Canadian physician, named the condition as Eisenmenger’s complex(1936)  Paul Wood, a British Cardiologist, defined this pulmonary HTN with reversed shunt as Eisenmenger’s syndrome(1958)
  • 25. It is a multisystem disorder involving :  Red cell mass, Hemostasis  Systemic vascular bed  CNS  Bilirubin kinetics  Coronary circulation and Myocardium  Uric acid Clearence  Kidney  Respiratory system  Digits and long bones  Gynecologic endocrinology
  • 26. PATHOPHYSIOLOGY Right  Left shunt Cyanosis + ↓Tissue Oxygenation Arterial Hypoxemia Adaptive Erythrocytosis ↑ Hematocrit ↑ RBC turnover & Hemolysis Indirect Bilirubinemia+Gall Stones EXTRAMURAL CORONARY ECTASIA Iron Deficiency(≤ 4 yrs) CEREBRAL VENOUS THROMBOSIS Paradoxical Emboli STROKE Thrombocytopenia(≥ 50yrs) + Abnormal vWF Muco-cutaneous bleeding Easy Bruising, Epistaxis, Gingival bleeding, Menorrhagia, PULM.HEMORRHAGE(MOST SERIOUS) SUDDEN DEATH ↑ Shear stress in blood vessels ↑ NO,PGs SYSTEMIC VASCULAR DILATION SYNCOPE Dilation of Hilar Arterioles + Glomerular Capillaries ↑ PGDF,TGF β PROTENURIA + GLOMERULOPATHY Remodelling of Coronary Microvasculature ↓ CORONARY VASCULAR RESERVE CLUBBING+HYPERTROPHIC OSTEOARTHROPATHY Hyperuricemia Renal Calculi,Gouty Arthritis
  • 27.
  • 28. GERBODE DEFECT ~0.08% of CHD  LV–RA communications - congenital >> acquired-Post-MI, trauma, surgical, IE  First mentioned in 1838 by Thurnam J. On aneurisms of the heart with cases(Autopsy report)  First diagnosed by Kirby et al in a living patient directly on O.T table,18 Jan.1956 and closed it successfully through right thoracotomy by inflow occlusion + Hypothermia  In 1958, Gerbode et al successfully performed surgery on five patients with this anomaly and named it Gerbode defect  Caused by an anatomic deficiency of the membranous septum The Gerbode Defect: Left Ventricular to Right Atrial Communication—Anatomic, Hemodynamic, and Echocardiographic Features - SILBIGER, ET AL - ECHOCARDIOGRAPHY: A Jrnl. of CV Ultrasound & Allied Tech - 2009
  • 29. Modified Riemenschneider and Moss Classification 1/3rd cases associated with other anomalies – most common being ASD(PFO/Secumdum ASD)
  • 30. Aneurysmal transformation – Wu et al Morphogenetic process for Infra-valvular shunts
  • 31. LV  RA Large Systolic ∆ + Small Diastolic ∆ SHUNT depends on Size & PVR Large Shunt RA/RV Enlarged ↑ RV preload  LV LA/LV Enlarged Severe PAH may develop but uncommon Biventricular overload Acute/Chronic Heart Failure RL shunt caused by (1) Diastolic flow reversal across defect (RALV) (2) continuous RALA shunt across PFO/OS-ASD
  • 32.  Asymptomatic to severe heart failure  Characteristic murmur : loud, harsh pansystolic, Grade III–VI, getting softer with inspiration, radiationing posteriorly and often associated with a thrill along the left sternal border – SEA GULL MURMUR  Raised JVP, liver pulsation, and peripheral edema indicating RHF
  • 33.
  • 34. NATURAL HISTORY  Refers to the progression of a disease process in an individual over time, in the absence of treatment  Spontaneous closure  Premature death  Pulmonary vascular disease  Development of aortic incompetence  Bacterial endocarditis  Development of infundibular PS
  • 35. Spon Closure Rate  Rate of spontaneous closure depends on SIZE and LOCATION of VSD  Muscular VSDs are more likely to close spontaneously, especially if they are not large  Small VSDs have a >50% chance of spontaneous closure by 5 years >80% chance by adolescence Saxena, et al .: Indian Guidelines for Management of CHDs - Annals of Pediatric Cardiology / Volume 12 / Issue 3 / Sept-Dec 2019
  • 36.  Perimembranous VSDs (accounted for most of the moderate to large VSDs) 39% required surgical closure 29% closed spontaneously by 6 years of age  Muscular VSDs – 3% required surgical closure 69% closed spontaneously by 6 years of age The natural history of ventricular septal defects - S W Turner, S Hunter, J P Wyllie
  • 37.  Most of the VSDs(~75%) close spontaneously within the first two years of life  Afterwards, the chance of spontaneous closure diminishes remarkably but extend till adolescence.  Muscular and membranous VSDs with diameters < 6 mm have the best chance of spontaneous closure Spontaneous closure of ventricular septal defects in the first year of life - Lin MH et al - J Formos Med Assoc. 2001
  • 38. Age-wise Probability of Spontaneous closure of Small VSD :  34% by 1 year  67% by 5 years  75% by 10.5 years
  • 39. Mech of closure  Adherence of tricuspid leaflet , or chordal tissue to the edges of VSD.  Growth & hypertrophy of septum around the defect  Negative pressure effect exerted by a high velocity stream flowing through the defect  Ventricular septal aneurysm  Prolapse of aortic cusp  Intrusion of a sinus of Valsalva aneurysm
  • 40. VSD unlikely to close  Sub-pulmonary  Juxta-arterial  Inlet  Mal-aligned  Gerbode defect  Very large Saxena, et al .: Indian Guidelines for Management of CHDs - Annals of Pediatric Cardiology / Volume 12 / Issue 3 / Sept-Dec 2019
  • 41. Premature death  About 10% of children with large VSDs die in 1st year, primarily due to congestive heart failure Saxena,
  • 42. Pul vascular disease In the historic series of Dr. Paul Wood, 52% of patients with large VSD developed irreversible pulmonary vascular disease with the onset in infancy in four-fifths of them  Common with Subpulmonary VSD  Chances of development of PVD with age (PVR > 8 U.m2) YR Probability 10 yr 10 % 20 yr 50 % 30 yr 80 % 40 yr 100 %
  • 43. Updated clinical classification for PAH associated with CHD, Nice, France, 2013.
  • 44. Development of AR – seen in 6% Mechanism :  Lack of support to aortic annulus : Diastolic prolapse of unsupported cusp.  Venturi effect : Cusp is sucked during systole More with Subaortic/ Juxtaarterial VSD and Smaller VSD
  • 45. Bacterial endocarditis : 2-3 decade, on right side  Among congenital heart disease, VSD is the most frequent anomaly in right- sided IE  One of the important indications for VSD closure  The incidence of IE among ventricular septal defects (VSD) was 0.2%- 2%  Baumgartner et al.Guidelines for the management of grown- up congenital heart disease (new version 2010). Eur Heart J. 2010.
  • 46. Development of infundibular PS : 13 % pts Gasul Syndrome :  VSD with acquired PS, Gasul found that about 5- 10 % VSD patients develop PS in follow up(JAMA 1957, circulation 1963)  Progressive right ventricular outflow tract obstruction (Gasul phenomenon) may develop in 13% and aortic regurgitation (AR) in 6% of patients